FDA Clearance Tracker · P040044-S078
MynxGrip and Mynx Ace Vascular Closure Device
Last checked: Nov 20, 2026Latest source record: Nov 16, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Nov 16, 2018
Approved
Time to decision
361 days
Received Nov 20, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040044-S078
- Device name
- MynxGrip and Mynx Ace Vascular Closure Device
- Applicant
- Cordis US Corporation
- Applicant location
- Miami Lakes, FL
- Received
- Nov 20, 2017
- Decided
- Nov 16, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040044
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval to add a new vendor for the hydrogel sealant components and to extend the shelf life of the hydrogel component to 25 months.
Source documents
Other decisions for Cordis US Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PRECISE PRO RX Transcarotid Stent SystemPMA supplement
P030047-S049 · Decided Apr 4, 2025 · 185 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.